拡張性心筋症および心不全は,フォスフォランバン内の変異によって引き起こされる
Joachim P Schmitt1, Mitsuhiro Kamisago, Michio Asahi
1Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, 200 Longwood Avenue, Boston, MA 02115, USA.
まとめ
フォスフォランバン (PLN) の遺伝性心不全変異は,心筋細胞のカルシウム処理を妨げます. 拡張性心筋症におけるこの発見は,心不全に対する新しい治療法につながる可能性があります.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- 心不全は,分子原因が十分に理解されていない,拡大する流行病です.
- 拡張性心筋症は,心不全の重要な形態である.
研究 の 目的:
- 遺伝性拡張性心筋症の分子原因を特定するために.
- フォスフォランバン突然変異が心不全を引き起こすメカニズムを理解する.
主な方法:
- 変異を特定するための遺伝子配列決定.
- 変異したフォスフォランバンを発現するトランスジェニックマウスモデルの作成.
- タンパク質機能とカルシウム処理を研究するための細胞および生化学的測定法.
主要な成果:
- フォスフォランバン (PLN) の残基9 (R9C) の支配的なArg --> Cysミスセンスの突然変異が,遺伝性拡張性心筋症の原因として特定されました.
- PLN (R9C) を持つトランスジェニックマウスは,心不全と早死を示した.
- 変異したPLN (R9C) タンパク質はタンパク質キナーゼA (PKA) を捕まえて,野生型のPLNのリン酸化を防止し,ミオサイトカルシウムトランジエンスを変化させます.
結論:
- PLN (R9C) 変異によって引き起こされる筋細胞カルシウム不調は,ヒトの心不全を引き起こす可能性があります.
- この発見は,カルシウム処理メカニズムをターゲットにすることで,心不全に対する潜在的な治療の道を開きます.
関連する概念動画
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


